Alex M. Brill

Combining extensive executive and legislative branch experience with immersive knowledge of public policy, economics, and health care matters, economic policy advisor Alex Brill advances clients’ interests with lawmakers, regulators, and other critical constituencies. Alex offers providers and suppliers a unique perspective on the business challenges they face and utilizes the language, strategy, and research tools needed to move public policy forward.

The guidance, political strategy, and economic analysis Alex offers clients cover a wide range of health care issues, including Medicare reimbursement, drug pricing, the FDA approval process, and the economics of biosimilars. Alex’s published health policy research includes an investigation of overspending on multi-source drugs in Medicaid, research on barriers to biosimilar utilization and related matters, policies to promote drug competition, and the consequences of certain taxes and fees within the Affordable Care Act.

While health care represents a substantial part of Alex’s background and current work, his experience extends to several other policy areas, including tax, pension, trade, energy, and budget matters. Alex gained this diversity in subject matter knowledge in his roles on Capitol Hill and in the White House.

Alex formerly served as the policy director and chief economist to the House Committee on Ways and Means. In that position, he oversaw a broad portfolio of legislative matters and led staff-level negotiations with House and Senate leadership offices and Senate Finance Committee and Senate HELP Committee staff.

Before his tenure at Ways and Means, Alex was an economist at the White House Council of Economic Advisers, where he provided advice and analyses on national and international economic policies for the president. In 2010, Alex served as a consultant advisor to the President’s Fiscal Commission (commonly known as the Bowles-Simpson Commission). Alex is also a senior fellow at the American Enterprise Institute.

In addition to leveraging his knowledge and experience on behalf of the firm’s clients, Alex has also been called as an expert witness in several patent litigation cases. He has testified more than a dozen times before Congress and regularly appears in the media to discuss the economy and public policy matters.